期刊文献+

PDGF-D与MPO在大肠癌组织中的表达及临床意义 被引量:3

Expression and clinical significance of PDGF-D and MPO in colorectal cancer
下载PDF
导出
摘要 目的探讨血小板源性生长因子D(PDGF-D)与髓过氧化物酶(MPO)在大肠癌组织和大肠腺瘤组织中的表达及其临床意义。方法通过免疫组织化学染色法检测大肠癌组织及大肠腺瘤组织中PDGF-D与MPO的表达及其相关性。采用免疫组化染色方法检测88例大肠癌石蜡包埋组织、72例大肠腺瘤组织中PDGF-D与MPO的表达,并分析MPO和PDGF-D的表达与大肠癌临床病理特征的关系。结果大肠癌组织中PDGF-D与MPO阳性表达率分别为85.23%、63.64%,均显著高于大肠腺瘤组织(34.72%、27.78%),差异有统计学意义(P<0.01)。PDGF-D与MPO在大肠癌组织中的表达呈正相关(r=0.29,P<0.05)。结论 PDGF-D与MPO可能参与了大肠癌的启动及发生过程,在大肠癌的发生、发展和转移过程中起着重要作用。 Objective To detect the expression and clinical significance of platelet-derived growth factor D (PDGF- D) and myeloperoxidase (MPO) in colorectal cancer and colorectal adenomas tissues. Methods The expression and relationship of PDGF-D and MPO were detected by immunohistochemistry in colorectal cancer and colorectal adenomas tissues. The expression of PDGF-D and MPO were detected by immunohistochemistry in 88 cases of colorectal cancer, 72 cases of colorectal adenomas, and the relationship of the expression of PDGF-D, MPO with clinical pathological pa- rameters was analyzed in the colorectal cancer tissues. Results The positive rates of PDGF-D and MPO in colorectal cancer were 85.23% and 63.64% , respectively, and both were significantly higher in colorectal cancer tissues than those in eolorectal adenomas tissues (34.72%, 28.56% ), the difference was statistically significant (P 〈 0. 01 ). The expression of PDGF-D was positively related to MPO in colorectal cancer tissues ( r = 0. 29, P 〈 0.05 ). Conclusion PDGF-D and MPO may be involved in the start and process of colorectal cancer, and they play important roles in the process of the occurrence, development and metastasis of colorectal cancer.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第1期26-28,共3页 Chinese Journal of Gastroenterology and Hepatology
基金 黑龙江省医药卫生科技项目(2011663)
关键词 大肠癌 血小板源性生长因子-D(PDGF-D) 髓过氧化物酶(MPO) Colorectal cancer Platelet-derived growth factor D (PDGF-D) Myeloperoxidase (MPO)
  • 相关文献

参考文献8

  • 1Schabath MB,Spitz MR,Zhang X. Genetic variants of myeloperoxidase and lung cancer riskp[J].{H}CARCINOGENESIS,2008,(06):1163-1166.
  • 2Wang Z,Kong D,LiY. PDGF-D signaling:A novel target in cancer therapy[J].{H}Current Drug Targets,2009,(01):38-41.
  • 3Andrae J,Gallini R,Betsholtz C. Role of platelet-derived growth factors in physiology and medicine[J].{H}Genes and development,2008,(10):1276-1312.
  • 4Wang Z,Kong D,Banerjee S. Down-regulation of plateletderived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-κB signaling[J].{H}CANCER RESEARCH,2007,(23):11377-11385.
  • 5Mika D,Guruvayoorappan C. Myeloperoxidase:the yin and yang in tumour progression[J].{H}Journal of Experimental Therapeutics and Oncology,2011,(02):93-100.
  • 6Jaganjac M,Poljak-Blazi M,Schaur RJ. Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression[J].{H}CLINICAL AND EXPERIMENTAL IMMUNOLOGY,2012,(02):178-185.
  • 7Branniqan AE,O'Commell PR,Hurley H. Neutrophil apoptosis is delayed in patient with inflammatory bowel disease[J].{H}SHOCK,2009,(05):361-366.
  • 8Sun Y,Yang F,Yan J. New anti-fibrotic mechanisms ofN-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced ilicosis[J].{H}Life Sciences,2010,(7-8):232-239.

同被引文献35

  • 1Clark ME, Smith RR. Liver - directed therapies in metastatic colorectal cancer[ J]. J Gastrointest 0ncol,2014,5 (5) :374 - 387.
  • 2Liu J, Liao S, Huang Y, et al. PDGF - D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer [ J]. Clin Cancer Res, 2011,17 ( 11 ) :3638 - 3648.
  • 3Ahmad A, Wang Z, Kong D, et al. Platelet - derived growth factor - D contributes to aggressiveness of breast cancer cells by up - regulating Notch and NF - kappaB signaling pathways [ J ]. Breast Cancer Res Treat 2011,126( 1 ) :15-25.
  • 4Devarajan E, Song YH, Krishnappa S, et al. Epithelial - mesenchymal transition in breast cancer lines is mediated through PDGF - D released by tissue -resident stem cells[ J]. Int J Cancer,2012,131 (5) :1023 - 1031.
  • 5Starkuviene V, Liebel U, Simpson JC, et al. High - content screening microscopy identifies novel proteins with a putative role in secretory membrane traffic[ J]. Genome Res,2004, 14(10A) :1948 - 1956.
  • 6Arh D, Huber W, Liebel U, et al. Functional profiling: from microar- rays via cell - based assays to novel tumor relevant modulators of the cell cycle [ J ]. Cancer Res,2005,65 ( 17 ) :7733 - 7742.
  • 7Guo L, Yang LY, Fan C, et al. Novel roles of Vmpl : inhibition metas- tasis and proliferation of hepatocellular carcinoma [ J ]. Cancer Sci, 2012,103(12) :2110 -2119.
  • 8Gilabert M, Vaccaro MI, Fernandez -Zapico ME, et al. Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemothera-peutic drugs[ J]. J Cell Physiol,2013,228 (9) : 1834 - 1843,.
  • 9Qian Q, Zhou H, Chen Y, et al. VMP1 related autophagy and apopto- sis in colorectal cancer cells: VMP1 regulates cell death [ J ]. Biochem Biophys Res Commun ,2014,443 ( 3 ) : 1041 - 1047.
  • 10Sauermann M, Sahin O, Sultmann H, et al. Reduced expression of vac- uole membrane protein 1 affects the invasion capacity of tumor cells[ J]. Oncogene ,2008,27 (9) : 1320 - 1326.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部